AstraZeneca Research Facilities - Lund, Sweden

Go to navigation
Go to content

Lund is one of Europe’s oldest university cities, situated in the south of Sweden in one of the world’s largest science/ biotechnology environments – the Medicon Valley.

Over 1,200 people work at our state of the art R&D facility in Lund where efforts are focused on respiratory diseases such as asthma, rhinitis and chronic obstructive pulmonary disease, as well as inflammatory diseases such as rheumatoid arthritis and osteoarthritis.

AstraZeneca Research Facilities - Lund, Sweden

Pulmicort and Symbicort were both developed here.

Not signed in

Page tools

Share price

London: 26.95 GBP
New York: 44.82 USD
Stockholm: 310.10 SEK

At 21-Nov-2009 02:22 GMT

Detailed share price

Introduction to AstraZeneca

Our responsibility

We continue to communicate openly on a range of issues, including:

Did you know

Contact us

Email enquiry form

This website is intended for people seeking information on the AstraZeneca International business. If you are in the US you should visit AstraZeneca US.

We also have national business sites which can be found under our list of AstraZeneca websites.

We also have specific national and international websites designed for patients and healthcare professionals. If you have a question you can contact us.